Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000254463 | SCV000302115 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000254463 | SCV000711802 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Asp1321Asp in exon 41 of COL4A4: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 3.63% (48/1322) o f African chromosomes by the 1000 Genomes Project (Phase 3; dbSNP rs116124529). |
Gene |
RCV000710849 | SCV000718782 | benign | not provided | 2019-02-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000710849 | SCV000841154 | benign | not provided | 2018-01-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000710849 | SCV001031838 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294116 | SCV002587706 | likely benign | Kidney disorder | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000254463 | SCV001977907 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000254463 | SCV001979668 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001828126 | SCV002078867 | benign | Alport syndrome | 2019-12-03 | no assertion criteria provided | clinical testing |